Abstract |
Genetically hypertensive rats receiving a high sodium content diet develop, within weeks of their birth, major alterations of tissues and blood vessels. The purpose of this study was to evaluate the effects of cicletanine, a synthetic antihypertensive drug, on the progress of genetic hypertension. Iffa Credo SHR-SP male rats aged 11 weeks were divided into 4 groups. One group was used as control and 3 groups were treated with oral cicletanine in doses of 10, 30 and 90 mg/kg/day respectively. The control group showed a high mortality rate due to a significant decrease of weight gain and a highly significant increase of blood pressure, these changes being associated with lesions of tissues and vessels in the brain, heart and kidneys. A curative treatment with cicletanine improved these parameters and was accompanied by good tissue preservation. The curative effect of cicletanine seems to be due to an increase in endogenous prostaglandin synthesis.
|
Authors | M T Droy-Lefaix, M M Ruchoux, P Berthet, F Bakri, D Bosquet, G Narcisse, G Guillemain |
Journal | Archives des maladies du coeur et des vaisseaux
(Arch Mal Coeur Vaiss)
Vol. 82 Spec No 4
Pg. 163-8
(Nov 1989)
ISSN: 0003-9683 [Print] France |
Vernacular Title | Efficacité du ciclétanine sur les lésions du rat spontanément hypertendu. Etude curative--relation dose-effet. |
PMID | 2514659
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Diuretics
- Pyridines
- cicletanine
|
Topics |
- Animals
- Brain Diseases
(etiology, pathology)
- Cardiomyopathies
(etiology, pathology)
- Diuretics
(therapeutic use)
- Dose-Response Relationship, Drug
- Hypertension
(complications, drug therapy, pathology)
- Kidney Diseases
(etiology, pathology)
- Male
- Organ Size
(drug effects)
- Pyridines
- Rats
- Rats, Inbred SHR
|